The increasing incidence of infectious diseases and the rise in the geriatric population is expected to drive the market for Immunoassay Analyzers.

The global Immunoassay Analyzers Market is forecasted to reach USD 26.40 Billion by 2027, according to a new report by Reports and Data. Immunoassay analyzer has a key benefit of monitoring transfusion medicine as in blood transfusion and organ transplant, which is likely to increase its demand. Few clinical immunoanalyzer employ automated analyzer to reduce manual intervention and chances of error as well as improve the workflow.

The increasing adoption of the immunoassay analyzer will boost the growth of the market. There is a rising prevalence of chronic and infectious diseases around the globe, requesting the need for early diagnosis. The growing demand for diagnostics is expected to be the key driving factor of the immunoassay analyzer market. Development in the sectors of genomics and proteomics has made the database of biomarkers expand by each day. The discovery and growing research on biomarkers of various diseases have led researchers and experts to use this knowledge to create new assays for diagnostics. Rising investments in R&D to develop new tests for the diagnosis of the diseases will promote the growth of the industry during the forecast period.

 The global pharma & healthcare market revenue growth is mainly driven by factors such as increasing research & development activities in the healthcare sector, rapid adoption of digital technologies, growing demand for advanced point-of-care diagnostics, and rising trends of telehealth and telemedicine. The COVID-19 pandemic has led to acute healthcare supply shortage, and rapid spread of the SARS-CoV-2 infection and rising government initiatives to develop COVID-19 vaccines have further driven market revenue growth.

To get a sample copy of the report, click on @ https://www.reportsanddata.com/sample-enquiry-form/3467

Top companies profiled in the report:

bioMerieux. Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Roche Diagnostics, Beckman Coulter, Inc., Diasorin S.p.A., Siemens Healthcare GmbH, Sigma Aldrich. Co. LLC., and Boditech Med, Inc, among others.

Global Immunoassay Analyzers Market: Regional Outlook

• North America
  • S.
  • Canada
• Europe
  • K.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Peru
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • A.E
  • Rest of Middle East & Africa

Global Immunoassay Analyzers Market Segmentation:

• Product Outlook (Revenue, USD Billion; 2017-2027)
  • Immunofluorescence analyzers
  • Enzyme-Linked Immunoassay (EIA)
  • Chemiluminescence Immunoassay
  • Radioimmunoassay
  • Consumables & Accessories
• Application Outlook (Revenue, USD Billion; 2017-2027)
  • Oncology
  • Therapeutic Drug Monitoring
  • Endocrinology
  • Cardiology
  • Infectious Disease Testing
  • Autoimmune Disease
  • Others
• End-User Outlook (Revenue, USD Billion; 2017-2027)
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes

 To get a Order on the report, click on: @ https://www.reportsanddata.com/report-pricing/3467

Further key findings from the report suggest

• The Enzyme-Linked Immunoassay (EIA) is used to commonly measure antigens, antibodies, glycoproteins, and proteins in biological samples. For instance, HIV infection diagnosis, measurement of cytokines, and pregnancy tests. The segment is forecasted to grow with a CAGR of 5.2% during the forecast period.
• Cancer/tumor profiling deploys a tumor-specific patient-focused approach for the treatment of cancer by precisely targeting the tumor of an individual patent. Predominantly, tumor profiling may be helpful in increasing the chances of a patient getting benefitted from prescribed therapies for disease treatment.
• The market in the Asia Pacific region is expected to grow at the fastest rate of 5.9% in the forecast period. The high growth of the APAC region is owing to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in R&D activities the diagnostic procedures, among others.

 Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3467

Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.

 About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]